4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

26
4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT

Transcript of 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Page 1: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

4

Joseph Lepselter, Director Clinical Department

March 1, 2012

DRAFT CONCEPT

Page 2: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

©כל הזכויות שמורות

Face Rejuvenation

4

Page 3: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Photos Courtesy: Fernando Stengel, M.D., Dermatologist,Buenos Aires, Argentina

Décolleté Rejuvenation

4

Page 4: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

©כל הזכויות שמורות

Hand Rejuvenation

4

Page 5: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Program

• The aim of the new program is to treat the major photodamaged photoaged face, décolleté and hand-related imperfections - pigmentation, laxity, rhytides and volume, using 4 Harmony XL advanced light and laser technology.

4

Page 6: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Objective

• The objective of the 460 rejuvenating program is to remove photodamaged photoaged skin pigmentations and superficial blood vessels, tighten the laxed aged skin, décolleté and the dorsal aspect of the hand

Page 7: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Background (I)

• Face, décolleté and hands are one of the first parts of the body to show signs of aging because they receive so much exposure.

• Sunlight, the elements and the natural aging process all contribute to the development of darkened spots, precancerous growths and a loss of fatty tissue.

Page 8: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Background (II)

• Veins become much more prominent with deepening color enhancement. The anatomy of the tendon becomes more accentuated.

• Skin wrinkles become much more prevalent with the loss of fullness and elasticity in the deep dermal layer.

• Intermetacarpal wasting becomes more enhanced with volume loss.

Page 9: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Photdamage

• The most typical cause of darkened areas of skin, brown spots or areas of discoloration is unprotected sun exposure. Once incorrectly referred to as liver spots, these pigment problems are not connected with the liver.

Page 10: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

The Aging Face, Décolleté, Hand

• Level I – Epidermis– Pigmentation– Vascular lesions

• Level II – Dermis– Rhytides– Laxity

• Level III – Hypodermis– Laxity

Page 11: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

460 RejuvenationPigmented/Vascular Lesions

Laxity

Texture, Tone

Rhytides

Page 12: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Rejuvenation Modules

Dye-SVL

QSW Pixel

IMPACT

iPixel Er:YAG

Page 13: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

iPixel Er:YAG

QSW

Dye-PL

NIR

Page 14: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Modules

• Dye-PL• NIR• Nd:YAG QSW Pixel• Er:YAG iPixel

• Light 500-600-nm• Light 800-1600-nm• Laser 1064-nm• Laser 2940-nm

Page 15: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Modules Intended Use

• Dye-PL

• NIR• Nd:YAG QSW Pixel

• Er:YAG iPixel

• Vascular/pigmentation shading

• Topical Heating• Non-ablative skin

remodeling• Fractional ablative

skin remodeling

Page 16: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Dye-PL Indications

• Vascular & Pigmented Lesions– port wine stains – facial telangiectasia– Rosacea– Solar lentigenis

Page 17: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

iPixel Er:YAG Indications• Fractional skin resurfacing

• Fine-lines and wrinkles

• Skin laxity

• Scars including acne scars

• Stretch marks

• Photodamaged and photoaged skin

Page 18: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

QSW Pixel Indications

• Fractional skin resurfacing • Fine-lines and wrinkles• Skin laxity• Scars including acne scars• Stretch marks• Photodamaged and photoaged skin

Page 19: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

QSW Pixel Secondary Indications

• Crows feet• Frontal lines• Melasma• Deeper dark scars• Deeper pigmentation• Dark eye circle• Unwanted dermal filler / lumps from dermal filler• Rosacea• Telangiectasia

 

Page 20: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

NIR Indications

• Skin tightening

Page 21: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Protocol

Day 1 Color + Tightening Dye-PL, NIR

Day 20 Color +Tightening QSW, NIR

Day 30 Rhytides iPixel Er:YAG

Day 50 Color +Tightening Dye-PL, NIR

Day 60 Rhytides iPixel Er:YAG

4

Page 22: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Before After 4th txt

Page 23: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Bef

ore

3 w

eeks

Aft

er 1

Tx

Page 24: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Before

3 weeks After 1 Tx

Page 25: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Before R 3 weeks After 1 Tx

Page 26: 4 Joseph Lepselter, Director Clinical Department March 1, 2012 DRAFT CONCEPT.

Before 3 weeks After 1 TxL